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Complex regional pain syndrome (CRPS) presents with severe
pain in distal parts of a limb (hand or foot), typically after trauma
with associated swelling and warmth of the affected limb [33]. The
condition is associated with sensory abnormalities such as hyper-
sensitivity, and with autonomic disturbances including reddening
and sweating. At onset, CRPS is dominated by either a warm,
hyperemic, edematous limb (‘warm’ CRPS) or a cold, dystrophic
limb with skin atrophy (‘cold’ CRPS) and chronic pain [11,42]. Over
time, warm CRPS can progress to cold CRPS. This complex clinical
picture has led to the assumption that inﬂammatory, vasomotor,
and maladaptive neuroplastic changes are involved in the develop-
ment and maintenance of CRPS [14].
This topical review raises the hypothesis that hypoxia caused by
capillary ﬂow disturbances may play an important role in the
development of CRPS and the subsequent maintenance of the con-
dition as it progresses from the initial warm phase to the chronic
cold phase.
2. Is tissue oxygenation impaired in CRPS?
Histological examination of muscle tissue from CRPS patients
who underwent amputation revealed gross thickening of capillary
basement membranes, pericyte loss, and, in some cases, capillarynecrosis [47] (Fig. 1). Such changes would be expected to disturb
capillary ﬂow patterns, and possibly muscle ischemia (low blood
ﬂow). The latter is supported by the cold and dystrophic appear-
ance of limbs in ‘cold’ CRPS [42], by magnetic resonance spectros-
copy studies that reveal muscle hypoxia [17], and by ﬁndings of
reduced skin oxygenation in CRPS [27]. However, other observa-
tions are difﬁcult to reconcile with ischemia being the sole cause
of CRPS. First, capillary changes and edema pressure have not been
shown to impair tissue blood ﬂow [41], and skin hypoxia cannot be
explained by edema alone [27]. Second, limb hyperperfusion has
been demonstrated in mixed populations of ‘warm’ and ‘cold’ CRPS
patients [34,41,43], although skin oxygenation is low in both
groups [27]. Third, oxygen extraction fraction is dramatically
reduced in CRPS [34,43], not elevated as one would expect in limb
ischemia. Taken together, these observations suggest that impaired
tissue oxygenation, rather than ischemia, is central to the
etiopathogenesis of CRPS.
3. Relation between tissue blood ﬂow and tissue oxygenation
revisited
We recently uncovered a fundamental limitation in the
assumed one-to-one correspondence between tissue blood ﬂow
(TBF) and tissue oxygenation [25]. The assumption is rooted in
the classic ﬂow-diffusion equation [38], which assumes that all tis-
sue capillaries are equally perfused. Normal tissue, however, dis-
plays considerable capillary transit time heterogeneity (CTH). We
generalized the ﬂow-diffusion equation to express tissue oxygena-
tion in terms of TBF, CTH, and tissue oxygen tension (PtO2) [25].
Fig. 2A shows the classic ﬂow-diffusion equation, and how tissue
oxygenation is reduced by increasing levels of CTH, at constant
Fig. 1. (A) Gross thickening of the basal membrane in a capillary from the soleus
muscle of a 46-year-old male CRPS patient [47]. Note the multiple basal membrane
layers with cell debris from pericytes between the laminae (arrows). (B) Normal
muscle capillary with a red blood cell, obtained from a 41-year-old female control
subject. Note the endothelial cell (e), pericyte (p), and thin surrounding basal
membrane (arrow). Although all patients in the study by van der Laan et al. [47]
revealed severe changes in capillary and basement membrane morphology, it
should be kept in mind that biopsy material from amputations invariably
represents tissue from severe cases of CRPS. Figure from van der Laan et al. [47],
reproduced with permission from the publisher.
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on both TBF and the parallel homogenization of capillary ﬂows. If
capillary ﬂow patterns are poorly regulated, a condition called cap-
illary dysfunction, blood passes through capillaries at transit times
too short to permit efﬁcient extraction of oxygen by the tissue. If
CTH is high, this ‘oxygen loss’ may in fact exceed the beneﬁts of
vasodilation—a phenomenon called malignant CTH. Paradoxically,
failure to suppress normal vasodilatory responses under these con-
ditions is predicted to result in uncontrolled hyperemia, tissue
hypoxia, and tissue damage, consistent with the so-called luxury
perfusion syndrome observed in several tissues after ischemia-
reperfusion [32]. If TBF responses can be suppressed, then the
resulting, lower PtO2 increases blood–tissue concentration gradi-
ents and oxygen extraction so that some level of tissue function
(eg, muscle work) can be maintained [25].
4. Blood ﬂow regulation in normal muscle and skin
The sympathetic nervous system is involved in the regulation of
resting blood ﬂow in skin and muscle. In muscle, vessel tone is
under baroreceptor control for blood pressure maintenance, and
vascular innervation by a1 and a2 adrenergic ﬁbers suppress
resting blood ﬂow so that sudden removal of sympathetic
tone increases muscle blood ﬂow 2- to 3-fold [22]. Meanwhile,stimulation of b2-adrenoreceptors causes vasodilation. During
muscle work, tissue hypoxia, low pH, and the release of adenosine
and nitric oxide increases blood ﬂow. Muscle blood ﬂow is inter-
rupted by muscle contractions, and sustained tetanic contractions
such as those used in an animal model of chronic pain [48] are thus
likely to result in muscle hypoxia. In skin, stimulation of adrenergic
ﬁbers causes vasoconstriction, and stimulation of cholinergic ﬁbers
causes vasodilation and an increase in blood ﬂow [26], although
the extent of active cholinergic vasodilation, especially on distal
body parts, remains under debate [39]. CRPS is localized to the
limbs where muscle and overlying skin most often receive their
blood supply from different vascular branches [44].
5. Blood ﬂow regulation and oxygen extraction fraction in CRPS
Skin blood ﬂow in CRPS can be subdivided according to three
distinct phases [15,30]. In the acute or ‘warm’ phase of CRPS, the
affected limb is usually warmer than the contralateral limb. This
has been ascribed to functional inhibition of the sympathetic vaso-
constriction of the dermal arterioles involved in thermoregulation
[50,51], to ongoing inﬂammation, and to increased blood ﬂow in
underlying muscle and soft tissue (see below) [41]. The acute
phase is often followed by an intermediate phase in which skin
blood ﬂow and temperature alternate between warm and cold
[15,30]. Then, some patients develop a cold or chronic phase of
CRPS [15,30], in which both nutritional and thermoregulatory skin
ﬂow is reduced. This hypoperfusion has been interpreted as
catecholamine hypersensitivity [15], but this hypothesis is not
supported by recent results [45]. Instead, increasing evidence
suggests that endothelium-dependent vasodilation is suppressed,
a condition called endothelial dysfunction [9,40]. Endothelial
dysfunction is associated with increased levels of reactive oxygen
species (ROS) in the arteriolar vessel walls, and reduced levels of
nitric oxide (NO), which relaxes vascular smooth muscle cells.
Long-term exposure of artery and arteriole walls to ROS and low
NO causes remodeling and thickening of the vessel walls, which
become more rigid and develop abnormal focal constrictions. Such
morphological changes are indeed observed in CRPS patients [10].
Muscle or whole-limb blood ﬂow regulation is difﬁcult to study
in CRPS. In patients with ‘warm’ CRPS, Matsumura et al. found
reduced pH and high venous oxygen saturation (low oxygen
extraction fraction) in the affected limb, and radiographic signs
consistent with fast blood transits and AV shunting [34]. In chronic
CRPS patients, Tan et al. reported reduced venous oxygen satura-
tion (high oxygen extraction fraction), profound thickening of cap-
illary endothelium and basement membranes in muscle, and
evidence of severe hypoxia [43]. In a mixed population of individ-
uals with ‘warm’ and ‘cold’ CRPS, of whom >90% showed severe tis-
sue edema, Schurmann et al. found elevated blood ﬂow in the
affected arm, but no correlation between skin temperature and
limb blood ﬂow [41].6. Inﬂammation and edema in CRPS
CRPS is associated with exaggerated inﬂammatory responses
[3] and increased vascular permeability to macromolecules in the
affected extremity [36]. It is generally assumed that the inﬂamma-
tion is neurogenic, mediated by the depolarization of small sensory
afferents, mainly nociceptive C-ﬁbers, in the skin. These depolari-
zations trigger the release of neuropeptides such as CGRP and
substance P (SP), which induce local inﬂammation, protein extrav-
asation, vasodilatation, and the release of cytokines [18]. Accord-
ingly, skin levels of SP, CGRP, and inﬂammatory cytokines are
elevated in CRPS [2,20,23,28]. Tissue hypoxia in itself may also eli-
cit inﬂammation by up-regulating nuclear factor–jB transcription
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Fig. 2. (A) Relation between tissue blood ﬂow (TBF; measured in mL/100 mL tissue/min), and tissue oxygenation, expressed as the maximum metabolic rate (mL O2/100 mL
tissue/min) that can be supported by the blood, according to the classic ﬂow-diffusion equation [38], which assumes negligible capillary transit time heterogeneity (CTH) (full
black curve). Dashed grey lines schematically show the effects of increasing levels of CTH, at ﬁxed tissue oxygen tension (PtO2) [25]. In normal tissue, CTH is high during rest,
but CTH is reduced in parallel with increases in TBF (B). This gives rise to efﬁcient oxygen extraction at higher TBF values, despite the decreasing slope of the classical ﬂow-
diffusion equation. Conversely, failure of CTH to fall during vasodilation, so-called capillary dysfunction, renders vasodilation inefﬁcient as a means of increasing tissue
oxygenation. Note how the grey curves increase little towards high TBF. The lower grey curve illustrates the malignant CTH phenomenon. Eventually, TBF can reach a limit
beyond which further vasodilation would reduce tissue oxygenation. Failure to suppress normal vasodilation during elevated metabolic needs would therefore lead to a
condition of uncontrolled hyperemia, tissue hypoxia, and severe tissue damage. This phenomenon resembles the luxury perfusion syndrome [32] observed in some organs
after tissue reperfusion. We hypothesize that this hemodynamic abnormality is present in ‘warm’ CRPS (C). If TBF responses can be suppressed, then the resulting reduction in
tissue oxygen tension will increase blood–tissue concentration gradients, and increase the oxygen extraction fraction. Suppression of normal ﬂow responses, for example, by
endothelial dysfunction, permits better oxygen extraction and some level of tissue function, for example, muscle work. We hypothesize that ‘cold’ CRPS is characterized by
suppression of resting and activity-related blood ﬂow (D).
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immune responses to protect the host, including the production
of tumor necrosis factor, a key pro-inﬂammatory cytokine [13].
7. Capillary dysfunction hypothesis of CRPS
We hypothesize that CTH is elevated in tissue injury and acute
inﬂammation as a result of the following: capillary compression by
increased interstitial pressure (which occurs at only half the pres-
sure needed for arteriolar compression) caused by local hemor-
rhage and edema [49]; capillary constriction due to vasoactive
blood break-down products [29]; and disturbed blood rheology
due to abnormal adhesion of erythrocytes and white blood cells
to the capillary wall in inﬂammation [35]. These factors have been
shown to disturb capillary ﬂow patterns and effectively shunt
blood through the capillary bed [35,49]. We hypothesize that the
increased blood ﬂow and reduced oxygen extraction in both skin
and muscle in ‘warm’ CRPS reﬂect failure to suppress TBF in the
presence of malignant CTH, that is, ‘luxury perfusion’. We further
speculate that that the high oxygen extraction fraction [43] found
in chronic ‘cold’ CRPS represents suppression of resting blood ﬂow
and blood ﬂow responses by endothelial dysfunction [40] to main-
tain tissue oxygenation. Vasospasms, rather than being the source
of ischemia CRPS and CRPS models [6,7], are thus predicted to com-
pensate for downstream capillary dysfunction by attenuating the
‘oxygen loss’ that occur as blood is shunted through the capillaries
at high ﬂow rates. We believe that the intrinsic ROS production
throughout these phases causes permanent capillary wall damage,
propagating the condition [43,47]. These scenarios are illustrated
in Fig. 2B to E.
The key events in the hypothesized CRPS etiology are prolonged
disturbances of CTH by the factors above, and oxidative damage to
capillary walls and tissue (Fig. 2). Nicotine up-regulates the expres-
sion of adhesion molecules in the capillary endothelium [1] and
increases leukocyte rolling [54]. Smoking would therefore be
expected to worsen capillary ﬂow disturbances and increase the
risk of developing CRPS, whereas prompt reduction of the tissue
swelling and inﬂammation would be expected to reduce the risk.
We speculate that these mechanisms may contribute to the
increased prevalence of smokers among CRPS patients [21] and
the beneﬁts of corticosteroid treatment in preventing CRPS [5].
Meanwhile, we speculate that administration of vitamin C (a ROS
scavenger) reduces the risk of developing CRPS [55] by attenuating
oxidative capillary wall damage.
8. Origin of pain in CRPS
The mechanisms by which ischemia might create pain have
been reviewed by Coderre et al. [7,37]. Brieﬂy, tissue hypoxia
would be expected to result in elevated lactate levels and acidosis
secondary to energy depletion, as observed in the muscle and skin
of CRPS patients [4,17,27]. Indeed, exercise increases pain in CRPS
patients [7], and increased lactate levels correlate with the degree
of pain in animal models [7]. Both nociceptor discharges in relation
to the initial injury, and ectopic discharges thought to occur in
C-ﬁbers in animal models of hypoxia and inﬂammation [7], are
likely to initiate and maintain central sensitization [53].
Meanwhile, tissue hypoxia and inﬂammation are also known to
increase the levels of pro-inﬂammatory cytokines thought to
produce neuropathic pain [12,52].9. Conclusion and perspectives
Based on a chronic postischemic pain model [8] and earlier
observations of vascular abnormalities in CRPS [6], Coderre et al.have proposed that CRPS is initiated by a compartment-like syn-
drome, during which injury-related edema compresses tissue
microvessels and causes severe ischemia [7] and that subsequent
reperfusion causes microvascular injury and a permanent state of
vasospasm, slow ﬂow, and deep tissue ischemia [6,7]. We have
extended this notion by proposing that capillary ﬂow disturbances,
rather than arteriolar compressions or vasospasms, and tissue
hypoxia rather than ischemia, may be central disease entities in
CRPS.
Direct demonstration that a reduction of tissue CTH alleviates
CRPS symptoms and improves TBF would support the prediction
that capillary dysfunction is central to CRPS etiopathogenesis.
Phosphodiesterase (PDE) inhibitors reduce platelet aggregation
[19], decrease blood viscosity [24], and increase the ﬂexibility of
erythrocytes [24]. By these hemorheologic effects, PDE inhibitors
would therefore be expected to reduce CTH, and hence improve
tissue oxygenation. The PDE inhibitor tadalaﬁl indeed improves
muscle force (indicative of improved muscle oxygenation) and
reduces pain in some CRPS patients [16]. We speculate that the
recent failure of tadalaﬁl to elevate limb temperature [37] is the
result of capillary dysfunction, which causes a dissociation
between tissue oxygenation on one hand, and limb blood ﬂow/
temperature on the other. Studies in a post-ischemic pain model
conﬁrm that systemic PDE [46], as well as topical PDE application
either alone or in combination with vasodilators [37], relieve allo-
dynia while reversing the suppression of ﬂow responses [31], con-
sistent with a role of elevated CTH and tissue hypoxia in this
model.
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